These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7677485)
1. Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer. Kucharczuk JC; Elshami AA; Zhang HB; Smythe WR; Hwang HC; Tomlinson JS; Amin KM; Litzky LA; Albelda SM; Kaiser LR Ann Thorac Surg; 1995 Sep; 60(3):593-7; discussion 597-8. PubMed ID: 7677485 [TBL] [Abstract][Full Text] [Related]
2. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy. Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512 [TBL] [Abstract][Full Text] [Related]
4. Use of protamine to augment adenovirus-mediated cancer gene therapy. Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770 [TBL] [Abstract][Full Text] [Related]
5. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Smythe WR; Kaiser LR; Hwang HC; Amin KM; Pilewski JM; Eck SJ; Wilson JM; Albelda SM Ann Thorac Surg; 1994 Jun; 57(6):1395-401. PubMed ID: 8010779 [TBL] [Abstract][Full Text] [Related]
6. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene. Elshami AA; Kucharczuk JC; Zhang HB; Smythe WR; Hwang HC; Litzky LA; Kaiser LR; Albelda SM Hum Gene Ther; 1996 Jan; 7(2):141-8. PubMed ID: 8788165 [TBL] [Abstract][Full Text] [Related]
7. A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma. Sterman DH; Molnar-Kimber K; Iyengar T; Chang M; Lanuti M; Amin KM; Pierce BK; Kang E; Treat J; Recio A; Litzky L; Wilson JM; Kaiser LR; Albelda SM Cancer Gene Ther; 2000 Dec; 7(12):1511-8. PubMed ID: 11228529 [TBL] [Abstract][Full Text] [Related]
8. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment. Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855 [TBL] [Abstract][Full Text] [Related]
9. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer. Oakley R; Phillips E; Hooper R; Wilson D; Partridge M Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644 [TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy. Fukazawa T; Matsuoka J; Naomoto Y; Maeda Y; Durbin ML; Tanaka N Cancer Res; 2008 Sep; 68(17):7120-9. PubMed ID: 18757427 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818 [TBL] [Abstract][Full Text] [Related]
12. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects]. Mohr S; Keith G; Rihn B Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830 [TBL] [Abstract][Full Text] [Related]
13. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295 [TBL] [Abstract][Full Text] [Related]
14. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Waheed I; Guo ZS; Chen GA; Weiser TS; Nguyen DM; Schrump DS Cancer Res; 1999 Dec; 59(24):6068-73. PubMed ID: 10626792 [TBL] [Abstract][Full Text] [Related]
15. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma. Pass HI Chest Surg Clin N Am; 1994 Aug; 4(3):497-515. PubMed ID: 7953481 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth. Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354 [TBL] [Abstract][Full Text] [Related]
19. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana. Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]